Effect of Combined Interventions on Pressure Pain Threshold

March 13, 2020 updated by: University of Pecs

Effect of End-range Mobilization in Addition to Conservative Therapy on Decrease of Pressure Pain Threshold

The effect of mobilizations on decrease of peripheral and central sensitivity has been proven in KOA. Furthermore, the effect of conservative therapy has also been proven in the increase of pain threshold in KOA. However, no study has investigated the effect of these interventions combined till date in KOA.

The aim of the present study is to investigate the short-term and long-term effect of end-range mobilization in addition to conservative therapy on decrease of pressure pain threshold in KOA.

Study Overview

Detailed Description

The positive effect of different manual mobilizations have been proven in the management of knee osteoarthritis (KOA). Pressure pain threshold, as a measure of somatosensory function, is a well-applied measurement technique for the pain perception in KOA. The effect of mobilizations on decrease of peripheral and central sensitivity has been proven in KOA. Furthermore, few studies has revealed the effect of conservative therapy as an effective intervention in the increase of pain threshold. However, no study has investigated the effect of these interventions combined till date in KOA, which could give a long-lasting effect in the decrease of sensitization in KOA.

Therefore, the aim of the present study is to investigate the short-term and long-term effect of end-range mobilization in addition to conservative therapy on decrease of pressure pain threshold in KOA.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Please Select
      • Harkány, Please Select, Hungary, 7815
        • Miklós Pozsgai

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • clinical classification criteria of knee osteoarthritis according to the American College of Rheumatology
  • categorization as End of Range Problem based on Maitland manual therapy
  • unilateral/bilateral moderate-to-severe symptomatic tibiofemoral KOA with radiographic evidence of Kellgren-Lawrence scale 2 or 3
  • pain during weight-bearing activities at least within 6 months
  • at least 90° knee flexion
  • sufficient mental status

Exclusion Criteria:

  • acute inflammation of the knee
  • total knee replacement in the opposite side
  • class II. obesity (body mass index>35kg/m2)
  • severe degenerative lumbar spine disease (e.g. spondylolisthesis)
  • systemic inflammatory arthritic or neurological condition
  • physiotherapy/balneotherapy attendance or manual therapy within 3 months
  • intraarticular injections in the prior 12 months
  • use of walking aid
  • contraindication for manual therapy
  • complex regional pain syndrome
  • cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: End-range mobilization
End-range mobilization performed in end-position of the knee joint
accessory technique applied on the tibiofemoral joint with the aim of increasing extensibility of the periarticular tissues
Experimental: Non end-range mobilization
Non end-range mobilization performed in loose-packed position of the knee joint
accessory technique applied on the tibiofemoral joint with the aim of alleviating pain
Placebo Comparator: Control
Sham technique performed in loose-packed position of the knee joint
hands-on cutaneous technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of peripheral sensitivity
Time Frame: following 3-week rehabilitation
peripheral sensitivity (pressure pain threshold) assessed at the local knee
following 3-week rehabilitation
change of peripheral sensitivity
Time Frame: following 3-month
peripheral sensitivity (pressure pain threshold) assessed at the local knee
following 3-month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of central sensitivity
Time Frame: following 3-week rehabilitation
central sensitivity (pressure pain threshold) assessed at the ipsilateral m. extensor carpi radialis longus
following 3-week rehabilitation
change of central sensitivity
Time Frame: following 3-month
central sensitivity (pressure pain threshold) assessed at the ipsilateral m. extensor carpi radialis longus
following 3-month
change of general pain intensity
Time Frame: following 3-week rehabilitation
general pain intensity from the previous week using the Visual Analogue Scale
following 3-week rehabilitation
change of general pain intensity
Time Frame: following 3-month
general pain intensity from the previous week using the Visual Analogue Scale
following 3-month
change of Timed Up and Go test
Time Frame: following 3-week rehabilitation
short test for measuring physical performance
following 3-week rehabilitation
change of Timed Up and Go test
Time Frame: following 3-month
short test for measuring physical performance
following 3-month
change of pain intensity during physical performance
Time Frame: following 3-week rehabilitation
pain intensity measured during the previously mentioned physical performance test using the 0-10 Numerating Pain Rating Scale, where 0 indicate no pain and 10 indicate worst imaginable pain
following 3-week rehabilitation
change of pain during physical performance
Time Frame: following 3-month
pain intensity measured during the previously mentioned physical performance test using the 0-10 Numerating Pain Rating Scale, where 0 indicate no pain and 10 indicate worst imaginable pain
following 3-month
degree of knee flexion during passive movement at the onset of knee pain
Time Frame: following 3-week rehabilitation
measurement of degree of knee flexion during passive movement at the onset of knee pain
following 3-week rehabilitation
degree of knee flexion during passive movement at the onset of knee pain
Time Frame: following 3-month
measurement of degree of knee flexion during passive movement at the onset of knee pain
following 3-month
strength of resistance of passive knee flexion at the onset of knee pain
Time Frame: following 3-week rehabilitation
measurement of strength of resistance arising from the anterior located tissues around the knee during passive knee flexion at the onset of pain
following 3-week rehabilitation
strength of resistance of passive knee flexion at the onset of knee pain
Time Frame: following 3-month
measurement of strength of resistance arising from the anterior located tissues around the knee during passive knee flexion at the onset of pain
following 3-month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Miklós Pozsgai, MSc, Zsigmondy Vilmos Spa and Balneological Hospital of Harkány

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2020

Primary Completion (Actual)

March 4, 2020

Study Completion (Actual)

March 4, 2020

Study Registration Dates

First Submitted

March 4, 2020

First Submitted That Met QC Criteria

March 13, 2020

First Posted (Actual)

March 17, 2020

Study Record Updates

Last Update Posted (Actual)

March 17, 2020

Last Update Submitted That Met QC Criteria

March 13, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteo Arthritis Knee

Clinical Trials on end-range mobilization

Subscribe